DVA News and Press, DaVita Inc. From 10/04/23

2023-10-04 21:46:29 ET Summary DaVita Inc. stock has been heavily sold in '23, trading below its 50-day moving average for the past 8 weeks. The company lacks economic value, and its reinvestment runway looks limited, producing sub-standard returns on capital. The market expec...

2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...

DaVita launches community health tour to provide free kidney screenings and education coast-to-coast PR Newswire Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER , ...

DaVita and Adtalem collaborate to address growing nephrology nursing shortage PR Newswire Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER , Sept. 12, 2023 /PRNewswire/ -- DaVita Inc...

DaVita Inc. to Participate in Fireside Chat with UBS PR Newswire DENVER , Sept. 11, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic...

2023-08-15 16:57:12 ET Billionaire Larry Robbins' Glenview Capital Management in Q2 2023 exited its stakes in Chinese e-commerce giant Alibaba ( NYSE: BABA ) and Google-parent Alphabet ( NASDAQ: GOOG ) ( NASDAQ: GOOGL ), while picking up new positions in IT serv...

2023-08-15 03:59:00 ET Summary Berkshire Hathaway's 13F stock portfolio value increased from ~$325B to ~$348B in Q2 2023. The top five positions in the portfolio are Apple Inc., Bank of America, American Express, Coca-Cola, and Chevron. Berkshire Hathaway repurchased ~3.92M Cl...

2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...

2023-08-07 15:04:56 ET More on DaVita DaVita Inc. ( DVA ) Q2 2023 Earnings Call Transcript DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold DaVita: A Strong Earnings Beat, Better Free Cash Flow Outlook, Upgrading To Buy DaVita, Fres...

2023-08-03 21:00:22 ET Image source: The Motley Fool. DaVita (NYSE: DVA) Q2 2023 Earnings Call Aug 03, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita (DVA) Q2 2023 Earnings Call Transcript